MEFLOQUINE Side Effects

5995867-X | Fatigue, Interstitial Lung Disease, Pulmonary Fibrosis, Pyrexia, Rash, Weight Decreased
on Dec 05, 2008 Female patient from , child 4 years of age, was diagnosed with malaria prophylaxis, infection (What is infection?), alveolitis and was treated with Mefloquine (View Usage). Patient experienced the following unwanted or unexpected effects: fatigue, interstitial lung disease, pulmonary fibrosis (What is pulmonary fibrosis?), pyrexia, rash (What is rash?), weight decreased. Mefloquine dosage: . During the same period patient was treated with ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), IMMUNE GLOBULIN NOS (View Immune Globulin Nos Review and Immune Globulin Nos Label ). Patient was hospitalized.

5880016-9 | Abnormal Behaviour, Anxiety, Convulsion, Delusion, Dizziness, Fear, Feeling Abnormal, Frequent Bowel Movements, Gastroenteritis
Patient was taking Mefloquine (View Usage). Patient had the following side effects: abnormal behaviour, anxiety (What is anxiety?), convulsion, delusion, dizziness (What is dizziness?), fear, feeling abnormal, frequent bowel movements, gastroenteritis (What is gastroenteritis?) on Sep 10, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 127.0 lb, was diagnosed with malaria prophylaxis and. Mefloquine dosage: 1 Tablet Weekly Po. During the same period patient was treated with SEASONIQUE (View Seasonique Review and Seasonique Label ), AMBIEN CR (View Ambien Cr Review and Ambien Cr Label ), DRAMAMINE (View Dramamine Review and Dramamine Label ), MACROBID (View Macrobid Review and Macrobid Label ). Patient was hospitalized.

5876479-5 | Abnormal Behaviour, Belligerence, Paranoia, Psychotic Disorder
Adverse event was reported on Sep 08, 2008 by a Male patient taking Mefloquine (View Usage) (Dosage: 250mg Weekly Po) was diagnosed with malaria prophylaxis and. Location: UNITED STATES , 18 years of age, weighting 195.0 lb, After Mefloquine was administered, patient had the following side effects: abnormal behaviour, belligerence, paranoia, psychotic disorder (What is psychotic disorder?). Patient was hospitalized.

5868957-X | Affect Lability, Cold Sweat, Crying, Depression, Disturbance In Attention, Divorced, Early Retirement, Emotional Disorder, Feeling Of Despair
on Sep 02, 2008 Male patient from UNITED STATES , weighting 140.0 lb, was diagnosed with malaria prophylaxis and was treated with Mefloquine (View Usage). Patient experienced the following unwanted or unexpected effects: affect lability, cold sweat, crying, depression (What is depression?), disturbance in attention, divorced, early retirement, emotional disorder, feeling of despair. Mefloquine dosage: Po.


5841157-5 | Activities Of Daily Living Impaired, Aggression, Anger, Bipolar Disorder, Confusional State, Feeling Abnormal, Hallucination, Impaired Work Ability, Mental Disorder
on Aug 07, 2008 Male patient from UNITED STATES , 29 years of age, weighting 175.0 lb, was diagnosed with malaria prophylaxis and was treated with Mefloquine (View Usage). Patient had the following side effects: activities of daily living impaired, aggression, anger, bipolar disorder (What is bipolar disorder?), confusional state, feeling abnormal, hallucination, impaired work ability, mental disorder. Mefloquine dosage: Once A Week Po. Patient was hospitalized.

5822351-6 | Grand Mal Convulsion, Upper Limb Fracture
Patient was taking Mefloquine (View Usage). After Mefloquine was administered, patient had the following side effects: grand mal convulsion, upper limb fracture on Jul 23, 2008 from UNITED STATES Additional patient health information: Male patient , 33 years of age, weighting 175.0 lb, was diagnosed with malaria (What is malaria?) and. Mefloquine dosage: . Patient was hospitalized.

5806523-2 | Mania, White Blood Cell Count Increased
Adverse event was reported on Jul 03, 2008 by a Male patient taking Mefloquine (View Usage) (Dosage: ) was diagnosed with malaria prophylaxis, bipolar i disorder, mania and. Location: , 63 years of age, Patient experienced the following unwanted or unexpected effects: mania, white blood cell count increased. During the same period patient was treated with ESKALITH CR (View Eskalith Cr Review and Eskalith Cr Label ), LUNESTA (View Lunesta Review and Lunesta Label ), QUETIAPINE FUMARATE (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ). Patient was hospitalized.

5786900-9 | Abnormal Dreams, Anxiety, Insomnia, Suicidal Ideation
on Jun 23, 2008 Male patient from UNITED STATES , weighting 186.0 lb, was diagnosed with malaria prophylaxis and was treated with Mefloquine (View Usage). Patient had the following side effects: abnormal dreams, anxiety (What is anxiety?), insomnia, suicidal ideation. Mefloquine dosage: 250mg Weekly Po. During the same period patient was treated with CIPRO (View Cipro Review and Cipro Label ), ALBENDAZOLE (View Albendazole Review and Albendazole Label ).

5767227-8 | Abnormal Dreams, Nightmare
on Jun 11, 2008 Female patient from UNITED STATES , 25 years of age, weighting 160.0 lb, was treated with Mefloquine (View Usage). After Mefloquine was administered, patient had the following side effects: abnormal dreams, nightmare. Mefloquine dosage: .

5724928-5 | Liver Disorder
Patient was taking Mefloquine (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder on Apr 30, 2008 from UNITED STATES Additional patient health information: Male patient , 41 years of age, weighting 200.0 lb, was diagnosed with malaria (What is malaria?) and. Mefloquine dosage: . Patient was hospitalized.

5694409-6 | Asthenia, Balance Disorder, Blood Cholesterol Increased, Dizziness, Dry Mouth, Hypotension, Paraesthesia
Adverse event was reported on Apr 03, 2008 by a Female patient taking Mefloquine (View Usage) (Dosage: 1 Tablet 1 Per Week) was diagnosed with foreign travel and. Location: UNITED STATES , 64 years of age, weighting 173.0 lb, Patient had the following side effects: asthenia, balance disorder, blood cholesterol increased, dizziness (What is dizziness?), dry mouth, hypotension, paraesthesia.

5618980-5 | Blood Lactate Dehydrogenase Increased, C-reactive Protein Increased, Eosinophilia, Eosinophilic Pneumonia, Hypoxia, Normochromic Normocytic Anaemia, Pyrexia, Red Blood Cell Sedimentation Rate Increased, Tachycardia
on Feb 04, 2008 Female patient from , 67 years of age, was diagnosed with malaria prophylaxis, tinea versicolour and was treated with Mefloquine (View Usage). After Mefloquine was administered, patient had the following side effects: blood lactate dehydrogenase increased, c-reactive protein increased, eosinophilia, eosinophilic pneumonia, hypoxia, normochromic normocytic anaemia, pyrexia, red blood cell sedimentation rate increased, tachycardia. Mefloquine dosage: . During the same period patient was treated with KETOCONAZOLE (View Ketoconazole Review and Ketoconazole Label ). Patient was hospitalized.

5609148-7 | Arthralgia, Dizziness, Hypoaesthesia, Impaired Work Ability, Myalgia
on Jan 30, 2008 Female patient from UNITED STATES , 33 years of age, was diagnosed with malaria prophylaxis and was treated with Mefloquine (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, dizziness (What is dizziness?), hypoaesthesia, impaired work ability, myalgia. Mefloquine dosage: Once Weekly.

5593124-7 | Road Traffic Accident, Vertigo Positional
Patient was taking Mefloquine (View Usage). Patient had the following side effects: road traffic accident, vertigo positional on Jan 14, 2008 from UNITED STATES Additional patient health information: Male patient , 36 years of age, weighting 223.1 lb, was diagnosed with malaria prophylaxis and. Mefloquine dosage: 250mg Qweek Po.

5564269-2 | Blood Lactate Dehydrogenase Increased, Eosinophilic Pneumonia, Hypoxia, Malaise, Normochromic Normocytic Anaemia, Pulmonary Toxicity, Tachycardia
Adverse event was reported on Dec 03, 2007 by a Female patient taking Mefloquine (View Usage) (Dosage: 250 Mg, Qw, Oral) was diagnosed with malaria prophylaxis, tinea versicolour and. Location: GREECE , 67 years of age, After Mefloquine was administered, patient had the following side effects: blood lactate dehydrogenase increased, eosinophilic pneumonia, hypoxia, malaise, normochromic normocytic anaemia, pulmonary toxicity, tachycardia. During the same period patient was treated with KETOCONAZOLE (Topical) (View Ketoconazole Review and Ketoconazole Label ). Patient was hospitalized.

5512218-5 | Anorexia, Feeling Abnormal, Influenza Like Illness, Nervousness, Palpitations, Panic Attack, Pyrexia, Sleep Disorder, Tremor
on Nov 08, 2007 Male patient from UNITED STATES , weighting 175.0 lb, was diagnosed with malaria prophylaxis and was treated with Mefloquine (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, feeling abnormal, influenza like illness, nervousness, palpitations, panic attack, pyrexia, sleep disorder (What is sleep disorder?), tremor. Mefloquine dosage: 1 Tablet Once A Week For 5 One Pill Per Week.

5498506-X | Abnormal Dreams, Alopecia, Confusional State, Depression, Insomnia, Sleep Terror, Syncope, Vertigo
on Oct 25, 2007 Female patient from UNITED STATES , 24 years of age, weighting 170.0 lb, was diagnosed with malaria prophylaxis and was treated with Mefloquine (View Usage). Patient had the following side effects: abnormal dreams, alopecia, confusional state, depression (What is depression?), insomnia, sleep terror, syncope, vertigo. Mefloquine dosage: One Tablet Weekly Two Years Po. During the same period patient was treated with PRIMAQUINE (2 Tablets Daily 1x14 Days Po) (View Primaquine Review and Primaquine Label ).

5494663-X | Depression, Fear, Suicidal Ideation
Patient was taking Mefloquine (View Usage). After Mefloquine was administered, patient had the following side effects: depression (What is depression?), fear, suicidal ideation on Oct 23, 2007 from UNITED STATES Additional patient health information: Male patient , 21 years of age, weighting 160.0 lb, was diagnosed with malaria prophylaxis and. Mefloquine dosage: 1 Per Week.

5452321-1 | Anxiety, Impaired Driving Ability, Mental Disorder, Panic Attack
Adverse event was reported on Sep 12, 2007 by a Female patient taking Mefloquine (View Usage) (Dosage: 250 Mg Weekly Po Dose Taken) was diagnosed with malaria prophylaxis and. Location: UNITED STATES , 32 years of age, weighting 175.0 lb, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), impaired driving ability, mental disorder, panic attack.

5435071-7 | Rash Pruritic, Urticaria
on Aug 28, 2007 Female patient from UNITED STATES , 27 years of age, weighting 125.0 lb, was treated with Mefloquine (View Usage). Patient had the following side effects: rash pruritic, urticaria. Mefloquine dosage: 1 Tablet Once A Week Po.

5429208-3 | Chest Pain, Fear, Heart Rate Decreased, Initial Insomnia, Palpitations, Panic Reaction
on Aug 27, 2007 Male patient from UNITED STATES , 22 years of age, weighting 143.3 lb, was diagnosed with malaria prophylaxis and was treated with Mefloquine (View Usage). After Mefloquine was administered, patient had the following side effects: chest pain (What is chest pain?), fear, heart rate decreased, initial insomnia, palpitations, panic reaction. Mefloquine dosage: 250mg Once A Week Po.

5427445-5 | Anxiety, Dizziness, Fatigue, Fear, Impaired Work Ability
Patient was taking Mefloquine (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), dizziness (What is dizziness?), fatigue, fear, impaired work ability on Aug 24, 2007 from UNITED STATES Additional patient health information: Female patient , 26 years of age, weighting 126.0 lb, was diagnosed with malaria prophylaxis and. Mefloquine dosage: 250 Mg Once A Week Po.

5392183-4 | Myalgia, Pain In Extremity, Swelling, Tendonitis
Adverse event was reported on Jul 17, 2007 by a Female patient taking Mefloquine (View Usage) (Dosage: 1 Once A Week Po) was diagnosed with malaria prophylaxis and. Location: UNITED STATES , 48 years of age, weighting 140.0 lb, Patient had the following side effects: myalgia, pain in extremity, swelling, tendonitis.

5390014-X | Parkinsonism
on Jun 28, 2007 Male patient from TURKEY , 35 years of age, was treated with Mefloquine (View Usage). After Mefloquine was administered, patient had the following side effects: parkinsonism. Mefloquine dosage: .

5388633-X | Parkinsonism
on Jul 11, 2007 Male patient from , 35 years of age, was diagnosed with malaria prophylaxis and was treated with Mefloquine (View Usage). Patient experienced the following unwanted or unexpected effects: parkinsonism. Mefloquine dosage: .

5388628-6 | Maculopathy, Retinal Pigmentation
Patient was taking Mefloquine (View Usage). Patient had the following side effects: maculopathy, retinal pigmentation on Jul 13, 2007 from Additional patient health information: Male patient , 43 years of age, was diagnosed with malaria prophylaxis and. Mefloquine dosage: .

5385345-3 | Dizziness, Insomnia, Irritability, Mood Swings, Nightmare, Sleep Disorder
Adverse event was reported on Jul 09, 2007 by a Female patient taking Mefloquine (View Usage) (Dosage: Once Per Week Po) was diagnosed with malaria prophylaxis and. Location: UNITED STATES , weighting 130.0 lb, After Mefloquine was administered, patient had the following side effects: dizziness (What is dizziness?), insomnia, irritability, mood swings, nightmare, sleep disorder (What is sleep disorder?).

5350805-8 | Anxiety, Crying, Hallucination, Insomnia, Nightmare, Panic Attack, Paranoia, Tremor, Weight Decreased
on Jun 06, 2007 Female patient from UNITED STATES , 22 years of age, weighting 120.0 lb, was diagnosed with malaria prophylaxis and was treated with Mefloquine (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), crying, hallucination, insomnia, nightmare, panic attack, paranoia, tremor, weight decreased. Mefloquine dosage: 1 Pill Every 7 Days Po.

5316669-3 | Circadian Rhythm Sleep Disorder, Disorientation, Dizziness, Fatigue, Headache, Malaise, Nausea, Photophobia, Vision Blurred
on Apr 30, 2007 Female patient from UNITED STATES , 64 years of age, weighting 120.0 lb, was diagnosed with malaria prophylaxis and was treated with Mefloquine (View Usage). Patient had the following side effects: circadian rhythm sleep disorder, disorientation, dizziness (What is dizziness?), fatigue, headache (What is headache?), malaise, nausea (What is nausea?), photophobia, vision blurred. Mefloquine dosage: One Tab Weekly Prio, 10 Days After Lea Po.

5243672-4 | Condition Aggravated, Fatigue, Middle Insomnia, Sensitivity Of Teeth
Patient was taking Mefloquine (View Usage). After Mefloquine was administered, patient had the following side effects: condition aggravated, fatigue, middle insomnia, sensitivity of teeth on Feb 20, 2007 from UNITED STATES Additional patient health information: Male patient , 47 years of age, weighting 215.0 lb, was diagnosed with malaria prophylaxis and. Mefloquine dosage: Std 1/ Week Po.

5211569-1 | Maculopathy, Scotoma, Visual Acuity Reduced
Adverse event was reported on Jan 17, 2007 by a Female patient taking Mefloquine (View Usage) (Dosage: 250 Mg Po Qwk Po) was diagnosed with malaria prophylaxis and. Location: UNITED STATES , weighting 103.0 lb, Patient experienced the following unwanted or unexpected effects: maculopathy, scotoma, visual acuity reduced. During the same period patient was treated with ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ).

5191295-8 | Anorexia, Crying, Dizziness, Emotional Disorder, Hallucination, Hyperhidrosis, Hypoaesthesia, Insomnia, Myocardial Infarction
on Dec 19, 2006 Female patient from UNITED STATES , 42 years of age, weighting 140.0 lb, was diagnosed with malaria prophylaxis and was treated with Mefloquine (View Usage). Patient had the following side effects: anorexia, crying, dizziness (What is dizziness?), emotional disorder, hallucination, hyperhidrosis, hypoaesthesia, insomnia, myocardial infarction. Mefloquine dosage: 1 Tablet Weekly Po.

5165169-2 | Contusion, Platelet Count Increased, Rectal Haemorrhage
on Nov 15, 2006 Female patient from SINGAPORE , 46 years of age, was diagnosed with malaria prophylaxis and was treated with Mefloquine (View Usage). After Mefloquine was administered, patient had the following side effects: contusion, platelet count increased, rectal haemorrhage. Mefloquine dosage: Qw.

5159052-6 | Contusion, Platelet Count Increased, Rectal Haemorrhage
Patient was taking Mefloquine (View Usage). Patient experienced the following unwanted or unexpected effects: contusion, platelet count increased, rectal haemorrhage on Nov 21, 2006 from Additional patient health information: Female patient , 46 years of age, was diagnosed with malaria prophylaxis and. Mefloquine dosage: Once Weekly X 3 Weeks.

5118014-5 | Psychotic Disorder
Adverse event was reported on Sep 28, 2006 by a Female patient taking Mefloquine (View Usage) (Dosage: One Tablet Once A Week Po) was diagnosed with malaria prophylaxis and. Location: UNITED STATES , 28 years of age, weighting 135.0 lb, Patient had the following side effects: psychotic disorder (What is psychotic disorder?). Patient was hospitalized.

5109460-4 | Completed Suicide, Contusion, Haemothorax, Malaria, Mental Disorder, Wound
on Sep 19, 2006 Male patient from , 27 years of age, was diagnosed with malaria (What is malaria?), malaria prophylaxis and was treated with Mefloquine (View Usage). After Mefloquine was administered, patient had the following side effects: completed suicide, contusion, haemothorax, malaria (What is malaria?), mental disorder, wound (What is wound?). Mefloquine dosage: . During the same period patient was treated with PROGUANIL CHLOROQUINE (View Proguanil-chloroquine Review and Proguanil-chloroquine Label ).

5109459-8 | Blood Lactate Dehydrogenase Increased, C-reactive Protein Increased, Chills, Cough, Cyanosis, Dyspnoea, Headache, Hypoxia, Leukocytosis
on Sep 12, 2006 Female patient from , 60 years of age, was diagnosed with malaria prophylaxis, arteriosclerosis, hypertension, hyperlipidaemia and was treated with Mefloquine (View Usage). Patient experienced the following unwanted or unexpected effects: blood lactate dehydrogenase increased, c-reactive protein increased, chills, cough, cyanosis, dyspnoea, headache (What is headache?), hypoxia, leukocytosis. Mefloquine dosage: 250 Mg X 1 Dose. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), CIPROFIBRATUM (View Ciprofibratum Review and Ciprofibratum Label ). Patient was hospitalized.

5104007-0 | Blood Lactate Dehydrogenase Increased, Cyanosis, Headache, Hypoxia, Interstitial Lung Disease, Leukocytosis, Myalgia, Rales, Respiratory Distress
Patient was taking Mefloquine (View Usage). Patient had the following side effects: blood lactate dehydrogenase increased, cyanosis, headache (What is headache?), hypoxia, interstitial lung disease, leukocytosis, myalgia, rales, respiratory distress on Sep 01, 2006 from BELGIUM Additional patient health information: Female patient , 60 years of age, was diagnosed with malaria prophylaxis and. Mefloquine dosage: 250 Mg, Qw. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), CIPROFIBRATE (View Ciprofibrate Review and Ciprofibrate Label ). Patient was hospitalized.

5093449-8 | Delusion, Delusion Of Grandeur, Delusion Of Reference, Disinhibition, Hallucination, Visual, Insomnia, Mania, Persecutory Delusion, Psychotic Disorder
Adverse event was reported on Aug 16, 2006 by a Male patient taking Mefloquine (View Usage) (Dosage: 250 Mg Per Week (250 Mg), Po) . Location: , 22 years of age, After Mefloquine was administered, patient had the following side effects: delusion, delusion of grandeur, delusion of reference, disinhibition, hallucination, visual, insomnia, mania, persecutory delusion, psychotic disorder (What is psychotic disorder?). Patient was hospitalized.

5087940-8 | Anorexia, Asthenia, Duodenitis, Gastritis, Infection, Leukocytoclastic Vasculitis, Nonspecific Reaction, Rash
on Aug 22, 2006 Male patient from UNITED STATES , 70 years of age, was diagnosed with malaria (What is malaria?) and was treated with Mefloquine (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, asthenia, duodenitis, gastritis, infection (What is infection?), leukocytoclastic vasculitis, nonspecific reaction, rash (What is rash?). Mefloquine dosage: Po. During the same period patient was treated with CHLOROQUINE (Po) (View Chloroquine Review and Chloroquine Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LORATADINE (View Loratadine Review and Loratadine Label ), PLAVIX (View Plavix Review and Plavix Label ), LOTREL (View Lotrel Review and Lotrel Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ). Patient was hospitalized.

5011974-2 | Abasia, Activities Of Daily Living Impaired, Areflexia, Arthropathy, Asthenia, Burning Sensation, Dysstasia, Hypoaesthesia, Hypotonia
on May 10, 2006 Male patient from INDIA , 50 years of age, was diagnosed with malaria prophylaxis and was treated with Mefloquine (View Usage). Patient had the following side effects: abasia, activities of daily living impaired, areflexia, arthropathy, asthenia, burning sensation, dysstasia, hypoaesthesia, hypotonia. Mefloquine dosage: 1000 Mg Day 1, 500 Mg Day 2, Po.

5011972-9 | Dermatitis, Infected Skin Ulcer, Polyneuropathy
Patient was taking Mefloquine (View Usage). After Mefloquine was administered, patient had the following side effects: dermatitis, infected skin ulcer, polyneuropathy on May 10, 2006 from INDIA Additional patient health information: Female patient , 40 years of age, was diagnosed with malaria prophylaxis and. Mefloquine dosage: 1000 Mg Course, Po.

4990843-8 | Abasia, Areflexia, Dysgraphia, Hypokinesia, Hypotonia, Neuropathy Peripheral, Polyneuropathy, Rash Erythematous
Adverse event was reported on Apr 20, 2006 by a Male patient taking Mefloquine (View Usage) (Dosage: See Image) was diagnosed with malaria (What is malaria?) and. Location: INDIA , 50 years of age, Patient experienced the following unwanted or unexpected effects: abasia, areflexia, dysgraphia, hypokinesia, hypotonia, neuropathy peripheral, polyneuropathy, rash erythematous. During the same period patient was treated with CHLOROQUINE PHOSPHATE (View Chloroquine Phosphate Review and Chloroquine Phosphate Label ).

4976519-1 | Anxiety, Chest Discomfort, Dyspnoea, Insomnia
on Apr 18, 2006 Female patient from UNITED STATES , 41 years of age, weighting 130.0 lb, was diagnosed with malaria prophylaxis and was treated with Mefloquine (View Usage). Patient had the following side effects: anxiety (What is anxiety?), chest discomfort, dyspnoea, insomnia. Mefloquine dosage: 250mg Once A Week Buccal.

4973397-1 | Panic Attack
on Apr 13, 2006 Male patient from UNITED STATES , 33 years of age, weighting 230.0 lb, was diagnosed with malaria prophylaxis and was treated with Mefloquine (View Usage). After Mefloquine was administered, patient had the following side effects: panic attack. Mefloquine dosage: 250 Mg Weekly P.o.. Patient was hospitalized.

4909064-X | Deafness
Patient was taking Mefloquine (View Usage). Patient experienced the following unwanted or unexpected effects: deafness on Feb 09, 2006 from UNITED STATES Additional patient health information: Male patient , weighting 150.0 lb, was diagnosed with malaria prophylaxis and. Mefloquine dosage: 250 Mg 3 X Within' 5 Days Po.

4879688-7 | Agitation, Anxiety, Asthenia, Depression, Dry Mouth, Dysphoria, Nausea, Sleep Disorder, Treatment Noncompliance
Adverse event was reported on Dec 27, 2005 by a Female patient taking Mefloquine (View Usage) (Dosage: 250 Mg/week X 8 Weeks (250 Mg), Po) was diagnosed with malaria prophylaxis and. Location: , 48 years of age, Patient had the following side effects: agitation, anxiety (What is anxiety?), asthenia, depression (What is depression?), dry mouth, dysphoria, nausea (What is nausea?), sleep disorder (What is sleep disorder?), treatment noncompliance. During the same period patient was treated with FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ). Patient was hospitalized.

4804112-X | Anxiety, Hallucination, Paranoia, Suicidal Ideation
on Oct 18, 2005 Female patient from UNITED STATES , 55 years of age, weighting 110.0 lb, was diagnosed with foreign travel and was treated with Mefloquine (View Usage). After Mefloquine was administered, patient had the following side effects: anxiety (What is anxiety?), hallucination, paranoia, suicidal ideation. Mefloquine dosage: 1 Every Week. During the same period patient was treated with WHITE SIDEL: GP 118 (View White Sidel: Gp 118 Review and White Sidel: Gp 118 Label ).

4770717-8 | Completed Suicide, Depression, Nightmare
on Sep 14, 2005 Male patient from UNITED STATES , 26 years of age, weighting 200.0 lb, was diagnosed with malaria prophylaxis and was treated with Mefloquine (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide, depression (What is depression?), nightmare. Mefloquine dosage: Once A Week.

4763450-X | Blood Insulin Increased, Hypoglycaemia, Insulin C-peptide Increased, Insulinoma, Neuroglycopenia
Patient was taking Mefloquine (View Usage). Patient had the following side effects: blood insulin increased, hypoglycaemia, insulin c-peptide increased, insulinoma, neuroglycopenia on Aug 22, 2005 from UNITED STATES Additional patient health information: Male patient , 31 years of age, was diagnosed with malaria prophylaxis and. Mefloquine dosage: Once/week.